ATALANTA THERAPEUTICS
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing its proprietary RNA interference platform.
ATALANTA THERAPEUTICS
Social Links:
Industry:
Biotechnology Life Science
Founded:
2018-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.atalantatx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
110 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Life Biosciences
Life Biosciences is a developer of drugs designed to promote longevity and find treatments for age-related diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
F-Prime Capital
F-Prime Capital investment in Series A - Atalanta Therapeutics
Official Site Inspections
http://www.atalantatx.com
- Host name: 104.136.227.35.bc.googleusercontent.com
- IP address: 35.227.136.104
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Atalanta Therapeutics" on Search Engine
Atalanta Therapeutics | LinkedIn
16. Atalanta Therapeutics | 6,092 followers on LinkedIn. Pioneering RNAi treatments for neurodegenerative diseases | We are a biotechnology company pioneering new …See details»
Atalanta Therapeutics - Crunchbase Company Profile & Funding
Last Funding Type Series A. Legal Name Atalanta Therapeutics. Company Type For Profit. Contact Email [email protected]. Atalanta Therapeutics is a …See details»
Atalanta Therapeutics Launches With $110 Million to Pioneer …
Jan 11, 2021 BOSTON-- ( BUSINESS WIRE )-- Atalanta Therapeutics, a biotechnology company pioneering new treatment options for neurodegenerative diseases, launched …See details»
Atalanta Therapeutics Strengthens Leadership Team with Key …
BOSTON, October 7, 2021 – Atalanta Therapeutics, a biotechnology company pioneering new treatment options for neurodegenerative diseases, today announced the expansion …See details»
Atalanta Therapeutics Strengthens Leadership Team with Key …
Oct 7, 2021 BOSTON-- ( BUSINESS WIRE )-- Atalanta Therapeutics, a biotechnology company pioneering new treatment options for neurodegenerative diseases, today …See details»
Atalanta Therapeutics launches to develop RNAi therapies for ...
Jan 14, 2021 Atalanta Therapeutics has launched with big plans to develop RNA interference (RNAi) therapies that will silence the expression of genes implicated in …See details»
Atalanta pioneers siRNA for neurodegenerative diseases
Feb 9, 2021 Atalanta Therapeutics launched in January, announcing partnerships with Biogen and Genentech and $110 million in series A financing. The company was born …See details»
Atalanta Therapeutics Company Profile 2024: …
71. Latest Deal Type. Series A. Latest Deal Amount. $110M. Investors. 3. General Information. Description. Developer of RNA interference therapeutics intended to treat neurodegenerative diseases.See details»
Atalanta Therapeutics - Funding, Financials, Valuation & Investors
Atalanta Therapeutics has raised a total of. $110M. in funding over 1 round. This was a Series A round raised on Jan 11, 2021. Atalanta Therapeutics is funded by F-Prime …See details»
www.atalantatx.com - Oligonucleotide Therapeutics Society
Company Description. Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases. Our founders’ groundbreaking …See details»
Alicia Secor - Board Member - G1 Therapeutics, Inc.
Ms. Secor currently serves as President and Chief Executive Officer of Atalanta Therapeutics, Inc., a privately held biotechnology company pioneering new treatment …See details»
Atalanta Therapeutics | VentureRadar
Location: USA. Founded in 2018. Private Company. Develops branched siRNA technology to treat neurodegenerative diseases by silencing gene expression in the CNS, based on …See details»
Atalanta Therapeutics - Updates, News, Events, Signals & Triggers
Jan 18, 2024 News • Mar 10, 2022. BioSpace — Atalanta Therapeutics Appoints Alfred Sandrock to Board of Directors. News • Jan 12, 2021. Fortune — The biggest unicorn in …See details»
Atalanta Therapeutics - Contacts, Employees, Board Members, …
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.See details»
Atalanta Therapeutics | CipherBio
Atalanta is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing their proprietary RNA interference platform. …See details»
Strategic Advisory for Leading Therapeutics Innovation Inc
2 days ago /CNW/ -- Strategic Advisory for Leading Therapeutics Innovation Inc. ... Organization Profile. Strategic Advisory for Leading Therapeutics Innovation Inc. …See details»
President and CEO @ Atalanta Therapeutics - Crunchbase
Summary. Overview. CB Rank (Person) 396,359. Primary Job Title President and CEO. Primary Organization. Atalanta Therapeutics. Location Greater Boston Area, United …See details»
Scientist/Senior Scientist, Oligonucleotide Chemistry » Atalanta ...
Building on our founders’ Nobel-prize winning discoveries in RNA interference, Atalanta Therapeutics is developing novel branched siRNA therapeutics to treat severe …See details»
Atalanta Therapeutics - Tech Stack, Apps, Patents & Trademarks …
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.See details»